CureTicket

CureTicket is a digital healthcare platform that connects doctors with patients and pharmacists to provide safe, accurate, and accessible medications.

CureTicket was incubated by the region's top university-based incubation/acceleration program: Venture Lab at the American University in Cairo (AUC Venture Lab). The startup was graduated on December, 3rd, 2019.

We are done with the validation and we are developing our MVP to launch very soon.

https://www.youtube.com/watch?v=xB2Bi81a5jw

The Middle East & Africa region has a population of 1.6B includes 700M internet users. The MEA Pharmaceutical Market has reached $25B in value.

We democratize digital prescriptions to tackle the 3rd Global Patient Safety Challenge: Medication without harm, as identified by the WHO.

Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually.

Our solution considers four primary services:

1. Appointment booking aggregator: either for online sessions or for offline visits in partnership with existing appointment booking startups.

2. It also facilitates e-prescribing for doctors to prepare and communicate a digital Rx in almost 40 seconds.

3. Patients will be able to order their medications from e-pharmacies to be delivered at their doorstep.

4. Moreover, during the treatment, they will be able to follow-up with their doctors using organized engagement tools built especially for this purpose.

Our addressable market is within the Middle East and Africa.

In general, we compete with:
1. Global e-prescribing platforms.
2. e-Medical Records systems
3. e-pharmacies and drug-fulfillment startups

The CureTicket business model is designed to fit low-income and the least developed countries.

However, we decided to differentiate ourselves by providing a practical solution that tackles a real pain for doctors in the region: a 40-sec digital prescribing platform instead of e-health records systems that are resisted by local doctors because of the cost, time-consuming, and the way they are supposed to operate.

Moreover, the platform provides post-consultation engagement for doctors and patients to ensure higher medication adherence.

** Revenue:
- 2020: 0
- 2021: 530,045.00

** Direct Cost:
- 2020: 36,791.00
- 2021: 241,943.20

** Gross Margin:
- 2020: (36,791.00)
- 2021: 288,101.80

** Operating Expenses:
- 2020: 83,950.00
- 2021: 142,059.00

** Operating Income:
- 2020: (120,741.00)
- 2021: 146,042.80

Net Profit:
-2020: % 0
-2021: 20.72%

** Freemium: for doctors & patients

** Transaction-based: booking appointment platforms, insurers, and e-pharmacies

** Subscriptions: Pharmaceuticals for e-detailing

- Platform Development & Maintainance
- Marketing
- Doctors onboarding

We are fundraising a preseed $150K for 15% equity.
The startup is incorporated in the European Union (Estonia) with a registered mark.

- User Experience
- Should be regulated for each and every country when we rollout

CureTicket was incubated by the region's top university-based incubation/acceleration program: Venture Lab at the American University in Cairo (AUC Venture Lab). The startup was graduated on December, 3rd, 2019.

1.TEIC Future Techpreneur Sep 2019.
2. Alexandria Winner @ Techne Drifts 2020.